New drug for urinary tract infections


United States

The US Food and Drug Administration has approved a new treatment for uncomplicated urinary tract (UTI) infections in women. Approximately one-half of all women experience at least one type of infection at least once in their lifetime. The drug, Pivya (pivmecillinam) is a narrow spectrum antibiotic which has been shown to be effective against infections caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus.